NOVAVAX INC (NVAX:NASDAQ)
$9.23 -0.36 (-3.7539%)
Analysed NOVAVAX INC (NVAX:NASDAQ) News Sources
Novavax (NVDA) Following Updated Nuvaxovid Approval Faces A Wide Fair Value Debate
29-08-2026
yahoo.com
How Expanded Nuvaxovid Royalties and Partner-led Execution Could Shape Novavax’s (NVAX) Investment Narrative
29-08-2026
yahoo.com
Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story?
01-09-2026
247wallst.com
Novavax to Participate in September Investor Conferences
02-09-2026
yahoo.com
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
07-09-2026
yahoo.com
Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference
10-09-2026
marketbeat.com
Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot
10-09-2026
marketbeat.com
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
15-09-2026
yahoo.com
Do Novavax’s (NVAX) New Partnerships Offset Policy Risks From The Protecting Approved Care Act?
16-09-2026
yahoo.com
Novavax (NVAX) Could Be 32% Above Fair Value On Medicare Policy Fears
16-09-2026
yahoo.com
What is the current price of NOVAVAX INC (NVAX:NASDAQ)?
The current price of NOVAVAX INC (NVAX:NASDAQ) is $9.23.
NOVAVAX INC (NVAX:NASDAQ) absolute price change since previous trading day?
The absolute price change of NOVAVAX INC (NVAX:NASDAQ) since the previous trading day is $-0.36.
NOVAVAX INC (NVAX:NASDAQ) percentage price change since previous trading day?
The percentage price change of NOVAVAX INC (NVAX:NASDAQ) since the previous trading day is -3.7539%.
What is the most recent average sentiment score for NOVAVAX INC (NVAX:NASDAQ)?
The most recent average sentiment score for NOVAVAX INC (NVAX:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for NOVAVAX INC (NVAX:NASDAQ)?
The most recent sentiment for NOVAVAX INC (NVAX:NASDAQ) is .
SEC-8K** Filing Available For NOVAVAX INC (NVAX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.